Delivery Order SPE2DB20D3505-SPE2DB24FT4R3
- Not listed
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $14,412.90 firm fixed price delivery order contract to provide Tivicay 50 mg tablets. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract, valued at $32,738.28, is a firm fixed price delivery order for the supply of Tivicay 50 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- This federal contract award is for the delivery of Tivicay 50 mg tablets to the Defense Logistics Agency (DLA) for a total ceiling value of $12,571.56. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $3,637.74 firm fixed-price delivery order is for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Cencora, Inc. holds a significant...
- This federal contract award, valued at $2,668.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- This federal contract award issued by the Defense Logistics Agency (DLA) is a delivery order valued at $16,182.64 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, with a completion date of September 19, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $3,744.21, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Tivicay 50 mg tablets and does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distribution companies in the world, Amerisourcebergen Corporation, has been awarded this delivery order contract as well as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,744.21 firm fixed price delivery order is for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $19,225.48 firm fixed-price delivery order is for the supply of Tivicay 50 mg tablets to support military and federal healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award, valued at $47,433.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Tivicay 50 mg tablets, a medication used to treat HIV/AIDS. The contract has an ultimate completion date of July 24, 2024 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT4R3Delivery Order
This federal contract award is for the delivery of Tivicay 50 mg tablets to the Defense Logistics Agency (DLA). The $3,637.74 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are for-profit organizations registered in the System for Award Management (SAM.gov). Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/13/23 |